Whole PROC Gene Sequencing to Explain Genetically Unresolved Protein C Deficiencies
Thrombosis and Haemostasis · 01.06.2026 · 126 (06) · 582-594
DOI: 10.1055/a-2668-5003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.06.2026. Verfasst von Laetitia Mauge und 13 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Hématologie biologique, AP HP, Hôpital Européen Georges Pompidou, Paris, France. Hauptthemen laut MEDLINE: Protein C Deficiency, Protein C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
With exon-focused approaches, a proportion of protein C (PC) deficiencies remains genetically unresolved. In these cases, deep intronic variation or structural variation could be causal. To identify the causal variation in unrelated patients presenting a PC deficiency in whom no genetic variation was found using conventional exploration. Whole PROC gene was analyzed using next generation sequencing (NGS) in probands with unexplained confirmed decreased PC clot activity after genetic exploration in our centres since 2000. The pathogenic impact of identified candidate variants was assessed using both in silico analysis (MaxEntScan and SpliceAI) and in vitro splicing assay in HeLa and Huh7 cell lines. Among 2,263 probands, 53 remained unexplained after conventional genetic exploration. Whole PROC gene sequencing was performed in 38/53 probands for which a DNA sample was available. In total, 9 candidate variants from 11 probands (29%) were identified. They corresponded to 7 single nucleotide variants, one 541 bp deletion, and one 1.298 kb balanced inversion. Both the 541 bp deletion and the large balanced inversion disrupted PROC and were considered as pathogenic. Among the seven deep intronic substitutions, splicing functional assay found a deleterious impact (intron retention in mature mRNA or pseudo-exon activation) for four of them: c.237 + 75G > A, c.535 + 936C > T, c.536–95G > A, and c.796 + 49G > T. Thus, these variants were classified as likely pathogenic. Finally, NGS allowed the identification of causal variants in 8/38 patients previously unsolved protein C deficiency (21%). This study highlights the value of NGS for whole PROC gene sequencing in unexplained protein C deficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Service d'Hématologie biologique, AP HP, Hôpital Européen Georges Pompidou, Paris, France.
- Université Paris Cité, Inserm, PARCC, Paris, France.
- Université Claude Bernard Lyon 1, UR 4609 Hémostase et thrombose, Lyon, France.
- Université Versailles-St-Quentin, Inserm, UMR 1179, St-Quentin en Yvelines, France.
- Laboratoire de Biologie Moléculaire, AP HP, Hôpital Ambroise Paré, Boulogne-Billancourt, France.
- Service de Médecine Génomique des Maladies Rares, Groupe Hospitalier Universitaire Centre, Hôpital Européen Georges Pompidou, Paris, AP-HP, France.
ORCID-Profile: Laetitia Mauge, Yohann Jourdy
Zitieren
APA
Mauge, L., Rial, C., Mazancourt, P., Helley, D., Présot, I., Billon, C., Labrouche-Colomer, S., Venisse, A., Dargaud, Y., Auribault, K., Bertil, S., Vinciguerra, C., Gandrille, S., & Jourdy, Y. (2026). Whole PROC Gene Sequencing to Explain Genetically Unresolved Protein C Deficiencies. Thrombosis and Haemostasis, 126(06), 582-594. https://doi.org/10.1055/a-2668-5003
Vancouver
Mauge L, Rial C, Mazancourt P, Helley D, Présot I, Billon C, et al. Whole PROC Gene Sequencing to Explain Genetically Unresolved Protein C Deficiencies. Thrombosis and Haemostasis. 2026;126(06):582-594. doi:10.1055/a-2668-5003
BibTeX
@article{Mauge2026,
author = {Mauge, Laetitia and Rial, Carla and Mazancourt, Philippe De and Helley, Dominique and Présot, Isabelle and Billon, Clarisse and Labrouche-Colomer, Sylvie and Venisse, Annabelle and Dargaud, Yesim and Auribault, Karine and Bertil, Sébastien and Vinciguerra, Christine and Gandrille, Sophie and Jourdy, Yohann},
title = {Whole PROC Gene Sequencing to Explain Genetically Unresolved Protein C Deficiencies},
journal = {Thrombosis and Haemostasis},
year = {2026},
volume = {126},
number = {06},
pages = {582--594},
doi = {10.1055/a-2668-5003}
}
EUVIMED